AQST — Aquestive Therapeutics Share News
0.000.00%
Last trade - 00:00- $590.87m
- $608.89m
- $44.55m
Brief: Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results And Provides Business Update On Key 2023 Objectives
Aquestive Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Inc Received Notice Of Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Aquestive Therapeutics Announces Completion Of FDA End-Of-Phase 2 Meeting For Aqst-109 (Epinephrine Sublingual Film)
Brief: Aquestive Therapeutics Reports Third Quarter 2022 Financial Results And Provides Business Update
Aquestive Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Assertio Holdings Signs Exclusive License For Sympazan Oral Film From Aquestive Therapeutics
Brief: Aquestive Therapeutics Licenses Sympazan® (Clobazam) Oral Film To Assertio Holdings, Inc.
Aquestive gains as district court dismisses antitrust claims
Brief: Aquestive Says U.S. District Court Entered Order Dismissing All Claims Against Co In Certain Lawsuit
U.S. STOCKS ON THE MOVE-Aquestive, Bassett Furniture, Amgen
Aquestive up on positive FDA feedback for allergy drug
Brief: Aquestive Therapeutics Receives Positive FDA Written Response For Aqst-109 Epinephrine Sublingual Film
Brief: Aquestive Therapeutics Enters License And Supply Agreement With Pharmanovia For Libervant™ (Diazepam) Buccal Film For European And MENA Markets
U.S. STOCKS ON THE MOVE-Hasbro, Blackberry, Altamira, Apple
U.S. STOCKS ON THE MOVE-Outlook Therapeutics, DoorDash, Generac
U.S. STOCKS ON THE MOVE-Gold miners, Merck, Big Tech stocks
U.S. STOCKS ON THE MOVE-Moderna, crypto stocks, energy firms